GW Pharmaceuticals PLC Holding(s) in Company (4820E)
11 May 2013 - 1:24AM
UK Regulatory
TIDMGWP
RNS Number : 4820E
GW Pharmaceuticals PLC
10 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
--------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals PLC
issuer
of existing shares to which voting rights
are
attached: (ii)
-------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic x
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------- -------
Other (please Change of custodian
specify):
------------------- -------------------------------------------------------- -------
3. Full name of person(s) subject Farallon Capital Management L.L.C
to the
notification obligation: (iii)
-------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):(iv)
-------------------------------------------- ----------------------------------------
5. Date of the transaction and date 7 May 2013
on
which the threshold is crossed
or
reached: (v)
-------------------------------------------- ----------------------------------------
6. Date on which issuer notified: 9 May 2013
-------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 5%
-------------------------------------------- ----------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------ --------------------------------------------- ---------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights (x)
Shares Voting shares
Rights
------------ ----------------- -------------------------- --------- ----------------------- ---------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------ --- ---- ------ ------- ------ ----- --------- ------------ --------- ------------- ------------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
----------------------- ------------------- ------------------------------ -------------------------- ------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
----------------- ---------------- --------------- ---------------- --------------------------- -----------------------
American Nominal Delta
depository
receipts
US36197T1034
----------------- ---------------- --------------- ---------------- ---- ---------- -----------
6720000 5.04%
------------------------------------------------------------- --------------------------- ---------- -----------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------------------------- -----------------------------------------------------
6720000 5.04%
--------------------------------------------------------------------- -----------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------------
10. Name of the proxy holder:
----------------------------------------------------- -------------------------------
11. Number of voting rights proxy holder will
cease
to hold:
----------------------------------------------------- -------------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
----------------------------------------------------- -------------------------------
The underlying shares to which the
13. Additional information: ADRs described in section 8. C relate
have yet to be admitted to trading
on AIM. Consequently, the ADRs are
(pending the shares' admission to
trading) financial instruments with
similar economic effect to a qualifying
instrument rather than qualifying
financial instruments. When the shares
are admitted to trading they will
become qualifying financial instruments.
---------------------------------------- --------------------------------------------
14. Contact name: Elizabeth Wallace
---------------------------------------- --------------------------------------------
15. Contact telephone number: +1 415 421 2132
---------------------------------------- --------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASSEFADDEFF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles